National Committee for Quality Assurance
1.-Appropriate testing for children with pharyngitis: percentage of children 2 to 18 years of age who were diagnosed with pharyngitis, dispensed an antibiotic and received a group A streptococcus (strep) test for the episode. This updates a previously published measure summary.
full-text:
National Quality Measures Clearinghouse | Appropriate testing for children with pharyngitis: percentage of children 2 to 18 years of age who were diagnosed with pharyngitis, dispensed an antibiotic and received a group A streptococcus (strep) test for the episode.
2.- Appropriate treatment for children with upper respiratory infection (URI): percentage of children 3 months to 18 years of age who were given a diagnosis of URI and were not dispensed an antibiotic prescription. This updates a previously published measure summary.
full-text:
National Quality Measures Clearinghouse | Appropriate treatment for children with upper respiratory infection (URI): percentage of children 3 months to 18 years of age who were given a diagnosis of URI and were not dispensed an antibiotic prescription.
3.- Asthma: percentage of members 5 to 50 years of age during the measurement year who were identified as having persistent asthma and who were appropriately prescribed medication during the measurement year. This updates a previously published measure summary.
full-text:
National Quality Measures Clearinghouse | Asthma: percentage of members 5 to 50 years of age during the measurement year who were identified as having persistent asthma and who were appropriately prescribed medication during the measurement year.
4.- Avoidance of antibiotic treatment in adults with acute bronchitis: percentage of adults 18 to 64 years of age with a diagnosis of acute bronchitis who were not dispensed an antibiotic prescription. This updates a previously published measure summary.
full-text:
National Quality Measures Clearinghouse | Avoidance of antibiotic treatment in adults with acute bronchitis: percentage of adults 18 to 64 years of age with a diagnosis of acute bronchitis who were not dispensed an antibiotic prescription.
5.- Chronic obstructive pulmonary disease (COPD): percentage of members 40 years of age and older with a new diagnosis or newly active COPD who received appropriate spirometry testing to confirm the diagnosis. This updates a previously published measure summary.
full-text:
National Quality Measures Clearinghouse | Chronic obstructive pulmonary disease (COPD): percentage of members 40 years of age and older with a new diagnosis or newly active COPD who received appropriate spirometry testing to confirm the diagnosis.
6.- Pharmacotherapy management of chronic obstructive pulmonary disease (COPD) exacerbation: percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED encounter between January 1 to November 30 of the measurement year and who were dispensed a bronchodilator within 30 days of the event. This updates a previously published measure summary.
full-text:
National Quality Measures Clearinghouse | Pharmacotherapy management of chronic obstructive pulmonary disease (COPD) exacerbation: percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED encounter between January 1 to November 30 of the measurement year and who were dispensed a bronchodilator within 30 days of the event.
7.- Pharmacotherapy management of chronic obstructive pulmonary disease (COPD) exacerbation: percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED encounter between January 1 to November 30 of the measurement year and who were dispensed a systemic corticosteroid within 14 days of the event. This updates a previously published measure summary.
full-text:
National Quality Measures Clearinghouse | Pharmacotherapy management of chronic obstructive pulmonary disease (COPD) exacerbation: percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED encounter between January 1 to November 30 of the measurement year and who were dispensed a systemic corticosteroid within 14 days of the event.
lunes, 7 de marzo de 2011
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario